ReviewFrontiers in genetics2020

Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications.

Giulia Occhipinti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.